Prediction of In Vivo Drug-Drug Interactions from In Vitro Data: Factors Affecting Prototypic Drug-Drug Interactions Involving CYP2C9, CYP2D6 and CYP3A4

By Brown Hayley S.   Galetin Aleksandra   Hallifax David   Houston J. Brian  

Clinical Pharmacokinetics, Vol. 45, Iss. 10, 2006-01 ,pp. : 1035-1050

Adis International

Access to resources Recommend Favorite

A Critical Evaluation of the Experimental Design of Studies of Mechanism Based Enzyme Inhibition, with Implications for In Vitro-In Vivo Extrapolation

By  

Current Drug Metabolism, Vol. 7, Iss. 3, 2006-04 ,pp. : 315-334

Bentham Science Publishers

Access to resources Recommend Favorite

Complexities of Glucuronidation Affecting In Vitro-In Vivo Extrapolation

By  

Current Drug Metabolism, Vol. 3, Iss. 6, 2002-12 ,pp. : 623-646

Bentham Science Publishers

Access to resources Recommend Favorite

Celecoxib is a CYP1A2 inhibitor in vitro but not in vivo

By Karjalainen Marjo   Neuvonen Pertti   Backman Janne  

European Journal of Clinical Pharmacology, Vol. 64, Iss. 5, 2008-05 ,pp. : 511-519

Springer Publishing Company

Access to resources Recommend Favorite

Quantitative Prediction of Glucuronidation in Humans Using the In Vitro- In Vivo Extrapolation Approach

By  

Current Topics in Medicinal Chemistry, Vol. 13, Iss. 11, 2013-06 ,pp. : 1343-1352

Bentham Science Publishers

Access to resources Recommend Favorite